Abstract
Purpose
The aim of the present paper was to determine (1) the incidence of failure (defined as the persistence or the recurrence of the infection), (2) the incidence of prosthesis (or even limb) loss (defined as the final need for an arthrodesis, resection arthroplasty or amputation) and (3) what factors could influence the failure in patients treated with a two-stage reimplantation for periprosthetic knee infections caused by resistant bacteria.
Methods
The authors retrospectively reviewed 29 total knee arthroplasties infected by resistant bacteria in 29 patients who underwent a two-stage revision. Between the stages, intravenous-targeted antibiotics were administered for a median period of 8 (range 6–12) weeks. Median follow-up was 10 (range 7–14) years.
Results
The authors found that failure occurred in 5 of 29 patients (17.2 %). When methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative staphylococci (MR-CoNS) were involved, failure rate was 10 % (2 of 20). When vancomycin-resistant enterococcus (VRE), multidrug-resistant (MDR) Acinetobacter baumannii and MDR Pseudomonas aeruginosa were involved, the failure rate was 33.3 % (3 of 9). Of those five patients, two underwent amputations, one chronic suppressive antibiotic therapy, one arthrodesis and one resection arthroplasty; among them, three lost the limb (10.3 % of the overall group). Timing of reimplantation and patient comorbidities did not significantly influence the failure.
Conclusions
Two-stage protocol resulted in a viable option for patients with infections by some resistant organisms (MRSA and MR-CoNS). However, when highly resistant organisms were involved (VRE, MDR Acinetobacter Baumannii and MDR Pseudomonas aeruginosa), the failure rate was much higher. In all cases of failure of the two-stage reimplantation, prosthesis (or even limb) loss occurred. Consequently, patients should be counselled that when highly resistant bacteria are involved, two-stage reimplantation could not be successful, with high final risk of prosthesis (or even limb) loss.
Level of evidence
Retrospective case series, Level IV.
Similar content being viewed by others
References
Andres LA, Casey WJ, Clarke HD (2009) Techniques in soft tissue coverage around the knee. Tech Knee Surg 8(2):119–125
Barberán J, Aguilar L, Carroquino G, Gimenez MJ, Sanchez B, Martinez D, Prieto J (2006) Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Am J Med 119(11):993.e7–993.e10
Bassetti M, Vitale F, Melica G, Righi E, Di Biagio A, Molfetta L, Pipino F, Cruciani M, Bassetti D (2005) Linezolid in the treatment of gram-positive prosthetic joint infection. J Antimicrob Chemother 55(3):387–390
Chiang ER, Su YP, Chen TH, Chiu FY, Chen WM (2011) Comparison of articulating and static spacers regarding infection with resistant organisms in total knee arthroplasty. Acta Orthop 82(4):460–464
Cordero-Ampuero J, Esteban J, Garcia-Rey E (2010) Results after late polymicrobial, gram-negative, and methicillin-resistant infections in knee arthroplasty. Clin Orthop Relat Res 468(5):1229–1236
Deirmengian C, Greenbaum J, Stern J, Braffamn M, Lotke PA, Booth RE Jr, Lonner JH (2003) Open debridement of acute gram-positive infections after total knee arthroplasty. Clin Orthop Relat Res 416:129–134
De Martino I, De Santis V, Sculco PK, D’Apolito R, Assini JB, Gasparini G (2015) Tantalum cones provide durable mid-term fixation in revision TKA. Clin Orthop Relat Res 473(10):3176–3182
Falagas ME, Kopterides P (2006) Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect 64(1):7–15
Fehring TK, Odum S, Calton TF, Mason JB (2000) Articulating versus static spacers in revision total knee arthroplasty for sepsis. The Ranawat Award. Clin Orthop Relat Res 380:9–16
Freeman MG, Fehring TK, Odum SM, Fehring K, Griffin WL, Mason JB (2007) Functional advantage of articulating versus static spacers in 2-stage revision for total knee arthroplasty infection. J Arthroplasty 22(8):1116–1121
Fulkerson E, Della Valle DJ, Wise B, Walsh M, Preston C, Di Cesare PE (2006) Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites. J Bone Joint Surg Am 88(6):1231–1237
Galasso O, Mariconda M, Calonego G, Gasparini G (2011) Physical, mechanical and pharmacological properties of coloured bone cement with and without antibiotics. J Bone Joint Surg Br 93(11):1529–1536
Galat DD, McGovern SC, Larson DR, Harrington JR, Hanssen AD, Clarke HD (2009) Surgical treatment of early wound complications following primary total knee arthroplasty. J Bone Joint Surg Am 91(1):48–54
Gaynes R, Edwards JR, System National Infections Surveillance (2005) Overview of nosocomial infections caused by Gram-negative bacilli. Clin Infect Dis 41(6):848–854
Gemmel CG, Edwards DI, Fraise AP, Gould K, Ridgway GL, Warren RE (2006) Guidelines for the prophylaxis and treatment of methicillin-resistant staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother 57(4):589–608
Haddad FS, Masri BA, Campbell D, Masri BA, Campbell D, McGraw RW, Beauchamp CP, Duncan CP et al (2000) The Prostalac functional spacer in two-stage revision for infected knee replacements. J Bone Joint Surg (Br) 82(6):807–812
Haleem AA, Berry DJ, Hanssen AD (2004) Mid-term to long-term follow-up of two stage reimplantation for infected total knee arthroplasty. Clin Orthop Relat Res 428:35–39
Harris LG, Richards RG (2006) Staphylococci and implant surfaces: a review. Injury 37:S3–S14
Hofmann AA, Goldberg T, Tanner AM, Kurtin SM (2005) Treatment of infected total knee arthroplasty using an articulating spacer: 2- to 12-year experience. Clin Orthop Relat Res 430:125–131
Hofmann AA, Kane KR, Tkach TK, Plaster RL, Camargo MP (1995) Treatment of infected total knee arthroplasty using an articulating spacer. Clin Orthop Relat Res 321:45–54
Hsu YC, Cheng HC, Ng TP, Chiu KY (2007) Antibiotic-loaded cement articulating spacer for 2-stage reimplantation in infected total knee arthroplasty. J Arthroplasty 22(7):1060–1066
Kilgus DJ, Howe DJ, Strang A (2002) Results of periprosthetic hip and knee infections caused by resistant bacteria. Clin Orthop Relat Res 404:116–124
Kourbatova EV, Halvosa JS, King MD, Ray SM, White N, Blumberg HM (2005) Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control 33(7):385–391
Kurd MF, Ghanem E, Steinbrecher J, Parvizi J (2010) Two-stage exchange knee arthroplasty: Does resistance of the infecting organism influence the outcome? Clin Orthop Relat Res 468(8):2060–2066
Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J (2010) Prosthetic joint infection risk after TKA in the medicare population. Clin Orthop Relat Res 468(1):52–56
Kutscha-Lissberg F, Hebler U, Muhr G, Köller M (2003) Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci. Antimicrob Agents Chemother 47(12):3964–3966
Lamagni T (2014) Epidemiology and burden of prosthetic joint infections. J Antimicrob Chemother 69(suppl 1):i5–i10
Laudermilch DJ, Fedorka CJ, Heyl A, Rao N, McGough RL (2010) Outcomes of revision total knee arthroplasty after methicillin-resistant Staphylococcus aureus infection. Clin Orthop Relat Res 468(8):2067–2073
Meek RM, Masri BA, Dunlop D, Garbuz DS, Greidanus NV, McGraw R, Duncan CP (2003) Patient satisfaction and functional status after treatment of infection at the site of a total knee arthroplasty with use of the PROSTALAC articulating spacer. J Bone Joint Surg Am 85-A(10):1888–1892
Mittal Y, Fehring TK, Hanssen A, Marculescu C, Odum SM, Osmon D (2007) Two-stage reimplantation for periprosthetic knee infection involving resistant organisms. J Bone Joint Surg Am 89(6):1227–1231
Mortazavi SM, Vegari D, Ho A, Zmistowski B, Parvizi J (2011) Two-stage exchange arthroplasty for infected total knee arthroplasty: predictors of failure. Clin Orthop Relat Res 469:3049–3054
Nazarian DG, de Jesus D, McGuigan F, Booth RE Jr (2003) A two-stage approach to primary knee arthroplasty in the infected arthritic knee. J Arthroplasty 18(7 suppl 1):16–21
Panni AS, Vasso M, Cerciello S (2013) Modular augmentation in revision total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 21(12):2837–2843
Panni AS, Vasso M, Cerciello S, Salgarello M (2011) Wound complications in total knee arthroplasty. Which flap is to be used? With or without retention of prosthesis? Knee Surg Sports Traumatol Arthrosc 19(7):1060–1068
Rao N, Ziran BH, Hall RA, Santa ER (2004) Successful treatment of chronic bone and joint infections with oral linezolid. Clin Orthop Relat Res 427:67–71
Ries MD (2001) Vancomycin-resistant Enterococcus infected total knee arthroplasty. J Arthroplasty 16(6):802–805
Romanò CL, Gala L, Logoluso N, Romanò D, Drago L (2012) Two-stage revision of septic knee prosthesis with articulating knee spacers yields better infection eradication rate than one-stage or two-stage revision with static spacers. Knee Surg Sports Traumatol Arthrosc 20(12):2445–2453
Samad A, Banerjee D, Carbarns N, Ghosh S (2002) Prevalence of methicillin-resistant Staphylococcus aureus colonization in surgical patients, on admission to a Welsh Hospital. J Hosp Infect 51(1):43–46
Sankar B, Hopgood P, Bell KM (2005) The role of MRSA screening in joint-replacement surgery. Int Orthop 29(3):160–163
Senneville E, Joulie D, Legout L, Valette M, Dezèque H, Beltrand E, Roselé B, d’Escrivan T, Loïez C, Caillaux M, Yazdanpanah Y, Maynou C, Migaud H (2011) Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus. Clin Infect Dis 53(4):334–340
Siddiqui MM, Lo NN, Ab Rahman S, Chin PL, Chia SL, Yeo SJ (2013) Two-year outcome of early deep MRSA infections after primary total knee arthroplasty: a joint registry review. J Arthroplasty 28(1):44–48
Silva M, Tharani R, Schmalzried TP (2002) Results of direct exchange or debridement of the infected total knee arthroplasty. Clin Orthop Relat Res 404:125–131
Singer J, Merz A, Frommelt L, Fink B (2012) High rate of infection control with one-stage revision of septic knee prostheses excluding MRSA and MRSE. Clin Orthop Relat Res 470(5):1461–1471
Vasso M, Beaufils P, Panni AS (2013) Constraint choice in revision knee arthroplasty. Int Orthop 37(7):1279–1284
Whiteside LA, Peppers M, Nayfeh TA, Roy ME (2011) Methicillin-resistant Staphylococcus aureus in TKA treated with revision and direct intra-articular antibiotic infusion. Clin Orthop Relat Res 469(1):26–33
Acknowledgments
The authors thank Dr. Marco De Gori for his help with the statistical analysis.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
This work was performed at the Department of Geriatrics, Neurosciences, and Orthopedics, Agostino Gemelli University Hospital, Catholic University of the Sacred Heart, Rome, Italy.
Rights and permissions
About this article
Cite this article
Vasso, M., Schiavone Panni, A., De Martino, I. et al. Prosthetic knee infection by resistant bacteria: the worst-case scenario. Knee Surg Sports Traumatol Arthrosc 24, 3140–3146 (2016). https://doi.org/10.1007/s00167-016-4010-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00167-016-4010-8